Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Leverages Genetics to Produce Potent CBD Strains Amid New Research Suggesting CBD Aids COVID-19 Patients
Austrian researchers report CBD reduces inflammation and speeds recovery in ICU COVID-19 patients Research suggests CBD’s anti-inflammatory properties stave off long-term neurological damage associated with COVID-19 PACR leverages genetic technology to produce potent CBD strains with higher yields per growing season Company catalog includes 350 cultivars and 50 super-elite strains prized in industry CBD may soon become the newest support in the world’s fight against COVID-19: Researchers at the Klagenfurt Clinic in Austria recently reported positive results from cannabidiol (“CBD”) trials on COVID-19 patients that demonstrated reduced inflammation and quicker recovery times (https://cnw.fm/gUeyW). Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF), a Canada-based…